American Association of Pharmaceutical Scientists (AAPS) PharmSci 360

November 3, 2019

Exhibit # 1324
Henry B. Gonzalez Convention Center, San Antonio, TX

Clinical & Pharmaceutical Solutions through Analysis (CPSA) USA

October 28, 2019

Sheraton Bucks County Hotel
Langhorne, PA USA

PBSS San Diego Workshop: Preclinical Development & IND (Investigational New Drug) Filing

October 11, 2019

Country Inn and Suites
San Diego, CA 

PBSS San Francisco Bay Workshop: Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends

October 3, 2019

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners
Presented by Katherine Yahvah, Ph.D.

Foster City Crowne Plaza
Foster City, CA

Alturas Major Sponsor Presentation - Pharmaceutical & BioScience Society

September 27, 2019

Meet with Alturas Analytics at this Important PBSS Workshop

"Small-Molecule Bioanalytical Method Validation & Regulated Bioanalysis: Fundamentals, the New FDA Guidance and Regulatory Trends"

Crowne Plaza
Foster City, CA
03 October 2019

Regulated bioanalysis (RBA) is required in the key parts of drug development that involve evaluations of drug safety, bioequivalence, and pharmacokinetics, and RBA data quality directly impacts the reliability of such assessments. Presenters at this workshop are internationally recognized experts on RBA and regularly present at international bioanalytical conferences.

SPONSOR PRESENTATION

Strategy for Implementation of 2018 FDA Bioanalytical Method Validation Guidance and Proactively Addressing the ICH M10 BMV Draft Guideline Internally and/or with Outsourcing Partners
Major Sponsor Presentation by Katherine Yahvah, Ph.D.

This talk will summarize feedback to the draft guideline from the perspective of a contract research organization working in the LC-MS/MS bioanalytical field. The general industry reaction to the ICH guidance and the major changes that we foresee as a result of its adoption will be presented. Read the Abstract  

Visit Alturas Analytics at the PBSS workshop or email Ann Hoffman ahoffman@alturasanalytics.com   or Lori Payne lpayne@alturasanalytics.com to set up a meeting and d iscuss strategies for implementation of the new guidance.

Scientist Focus - Jennifer Zimmer, Ph.D.

"The most rewarding part of my job is getting to see the impact that the novel compounds that we help analyze can have on the quality of life for patients."

Jennifer Zimmer, Ph.D. has been with Alturas Analytics since 2005. She has a vast background in bioanalytical as well as pharmacological science. As Laboratory Director, Dr. Zimmer is responsible for the overall operation and technical oversight of producing quality assays, generation of data and reports of the highest integrity and adapting to the changing landscape of the industry. She is an active participant in the Global CRO Council but is most proud of mentoring a team of scientists to be successful contributors in the bioanalytical industry.  Read her short question and answer session.

Upcoming Events

PBSS: Preclinical Development & IND (Investigational New Drug) Filing
Oct 11, 2019
Sponsor
Country Inn and Suites
San Diego, CA

CPSA USA
Oct 28 -31
Speaker: Shane Needham, Ph.D.
Sheraton Bucks County Hotel
Langhorne, PA

AAPS PharmSci 360
Nov 3 - 6, 2019
Speaker: Shane Needham, Ph.D.
Nov 4, 10 AM
Poster Presentation: Ashley Davie
Nov 6, 11:30 AM
Henry B. Gonzalez
Convention Center
San Antonio, TX